171 related articles for article (PubMed ID: 1406416)
1. Treatment of primary hypercholesterolaemia with pravastatin: efficacy and safety over three years.
Simons LA; Nestel PJ; Clifton P; Janus ED; Simons J; Parfitt A
Med J Aust; 1992 Nov; 157(9):584-9. PubMed ID: 1406416
[TBL] [Abstract][Full Text] [Related]
2. Comparative efficacy and safety of pravastatin and cholestyramine alone and combined in patients with hypercholesterolemia. Pravastatin Multicenter Study Group II.
Arch Intern Med; 1993 Jun; 153(11):1321-9. PubMed ID: 8507122
[TBL] [Abstract][Full Text] [Related]
3. Comparison of atorvastatin alone versus simvastatin +/- cholestyramine in the management of severe primary hypercholesterolaemia (the six cities study).
Simons LA
Aust N Z J Med; 1998 Jun; 28(3):327-33. PubMed ID: 9673745
[TBL] [Abstract][Full Text] [Related]
4. Successful management of primary hypercholesterolaemia with simvastatin and low-dose colestipol.
Simons LA; Simons J; Parfitt A
Med J Aust; 1992 Oct; 157(7):455-9. PubMed ID: 1406395
[TBL] [Abstract][Full Text] [Related]
5. Treatment of familial hypercholesterolaemia. United Kingdom lipid clinics study of pravastatin and cholestyramine.
Betteridge DJ; Bhatnager D; Bing RF; Durrington PN; Evans GR; Flax H; Jay RH; Lewis-Barned N; Mann J; Matthews DR
BMJ; 1992 May; 304(6838):1335-8. PubMed ID: 1611329
[TBL] [Abstract][Full Text] [Related]
6. Effect of combination therapy with lipid-reducing drugs in patients with coronary heart disease and "normal" cholesterol levels. A randomized, placebo-controlled trial. Harvard Atherosclerosis Reversibility Project (HARP) Study Group.
Pasternak RC; Brown LE; Stone PH; Silverman DI; Gibson CM; Sacks FM
Ann Intern Med; 1996 Oct; 125(7):529-40. PubMed ID: 8815751
[TBL] [Abstract][Full Text] [Related]
7. Compliance with and efficacy of treatment with pravastatin and cholestyramine: a randomized study on lipid-lowering in primary care.
Eriksson M; Hådell K; Holme I; Walldius G; Kjellström T
J Intern Med; 1998 May; 243(5):373-80. PubMed ID: 9651560
[TBL] [Abstract][Full Text] [Related]
8. Pravastatin and risk factor modification in patients with moderate primary hypercholesterolaemia.
Morris R; Robinson G; Tilyard M; Gurr E
N Z Med J; 1996 Aug; 109(1028):319-22. PubMed ID: 8816723
[TBL] [Abstract][Full Text] [Related]
9. Long-term treatment (2 years) with the HMG CoA reductase inhibitors lovastatin or pravastatin in combination with cholestyramine in patients with severe primary hypercholesterolemia.
Jacob BG; Richter WO; Schwandt P
J Cardiovasc Pharmacol; 1993 Sep; 22(3):396-400. PubMed ID: 7504129
[TBL] [Abstract][Full Text] [Related]
10. Combined therapy with probucol and pravastatin in hypercholesterolaemia. One year follow-up study.
Saku K; Zhang B; Hirata K; Okura Y; Bai H; Liu R; Arakawa K
Eur J Clin Pharmacol; 1993; 44(6):535-9. PubMed ID: 8405008
[TBL] [Abstract][Full Text] [Related]
11. Complementary effects of pravastatin and nicotinic acid in the treatment of combined hyperlipidaemia in diabetic and non-diabetic patients.
Tsalamandris C; Panagiotopoulos S; Sinha A; Cooper ME; Jerums G
J Cardiovasc Risk; 1994 Oct; 1(3):231-9. PubMed ID: 7621303
[TBL] [Abstract][Full Text] [Related]
12. [Pravastatin, cholestyramine and gemfibrozil in long-term therapy of primary hypercholesterolemia. An open randomized comparative study].
Ditschuneit HH; Dreyer M; Dammann HG; Ditschuneit H
Med Klin (Munich); 1991 Mar; 86(3):142-8. PubMed ID: 1903497
[TBL] [Abstract][Full Text] [Related]
13. Treatment of primary hypercholesterolaemia. Short-term efficacy and safety of increasing doses of simvastatin and pravastatin: a double-blind comparative study.
Stalenhoef AF; Lansberg PJ; Kroon AA; Kortmann B; De Haan AF; Stuyt PM; Kastelein JJ
J Intern Med; 1993 Jul; 234(1):77-82. PubMed ID: 8326293
[TBL] [Abstract][Full Text] [Related]
14. Simvastatin versus pravastatin: efficacy and tolerability in patients with primary hypercholesterolemia.
Malini PL; Ambrosioni E; De Divitiis O; Di Somma S; Rosiello G; Trimarco B
Clin Ther; 1991; 13(4):500-10. PubMed ID: 1934003
[TBL] [Abstract][Full Text] [Related]
15. Comparative efficacy and tolerability of 5 and 10 mg simvastatin and 10 mg pravastatin in moderate primary hypercholesterolemia. Simvastatin Pravastatin European Study Group.
Steinhagen-Thiessen E
Cardiology; 1994; 85(3-4):244-54. PubMed ID: 7987882
[TBL] [Abstract][Full Text] [Related]
16. Comparative efficacy study of atorvastatin vs simvastatin, pravastatin, lovastatin and placebo in type 2 diabetic patients with hypercholesterolaemia.
Gentile S; Turco S; Guarino G; Sasso CF; Amodio M; Magliano P; Salvatore T; Corigliano G; Agrusta M; De Simone G; Gaeta I; Oliviero B; Torella R
Diabetes Obes Metab; 2000 Dec; 2(6):355-62. PubMed ID: 11225965
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness and safety of low-dose pravastatin and squalene, alone and in combination, in elderly patients with hypercholesterolemia.
Chan P; Tomlinson B; Lee CB; Lee YS
J Clin Pharmacol; 1996 May; 36(5):422-7. PubMed ID: 8739021
[TBL] [Abstract][Full Text] [Related]
18. Influence of baseline lipids on effectiveness of pravastatin in the CARE Trial. Cholesterol And Recurrent Events.
Pfeffer MA; Sacks FM; Moyé LA; East C; Goldman S; Nash DT; Rouleau JR; Rouleau JL; Sussex BA; Theroux P; Vanden Belt RJ; Braunwald E
J Am Coll Cardiol; 1999 Jan; 33(1):125-30. PubMed ID: 9935018
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of a new cholesterol synthesis inhibitor, atorvastatin, in comparison with simvastatin and pravastatin, in subjects with hypercholesterolemia.
Wolffenbuttel BH; Mahla G; Muller D; Pentrup A; Black DM
Neth J Med; 1998 Apr; 52(4):131-7. PubMed ID: 9646621
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and pharmacodynamics of pravastatin alone and with cholestyramine in hypercholesterolemia.
Pan HY; DeVault AR; Swites BJ; Whigan D; Ivashkiv E; Willard DA; Brescia D
Clin Pharmacol Ther; 1990 Aug; 48(2):201-7. PubMed ID: 2116260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
